August 25th 2025
Leqembi for the treatment of Alzheimer disease has been launched in Austria on August 25, 2025, and will be launched in Germany on September 1, 2025—the first launches in the EU.
Evaluating Brexpiprazole for the Management of Behavioral and Psychological Symptoms of Dementia
In this CME article, learn more about the efficacy and tolerability of brexpiprazole for the treatment of agitation among individuals with Alzheimer disease dementia.
Read More
Effects of Noninvasive Neurostimulation on Sleep Quality and Symptoms in Depression
September 6th 2024Will this help my sleep and mood? Researchers investigated the effects of noninvasive neurostimulation on sleep quality and depressive symptoms in patients with major depressive disorder in a meta-analysis of randomized controlled trials.
Read More
Treatment Options for the Management of Behavioral and Psychological Symptoms of Dementia
The behavioral and psychological symptoms of dementia contribute significantly to the greater rates morbidity and mortality among those with dementia.
Read More
The Relationship Between Glucose Fluctuations and Cognition in Patients With Type 1 Diabetes
March 18th 2024A new study found that when glucose is either very high or low in patients with type 1 diabetes, cognition is slower; however, slightly above average glucose led to peak cognitive performance.
Read More